Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Ribonucleic Acid Ingredients should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Ribonucleic Acid Ingredients market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Ribonucleic Acid Ingredients market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Messenger RNA segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Fluorescent Dyes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Ribonucleic Acid Ingredients include BioNTech SE, Moderna, Abogen Biosciences, Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, LARONDE, Inc., Sirnaomics, Inc. and Deep Genomics, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
A synthesized from DNA by an enzyme known as RNA polymerase during a process called transcription.
This report aims to provide a comprehensive study of the global market for Ribonucleic Acid Ingredients.
Data-Driven Insights: Highlights from Our Report
(1) Global Ribonucleic Acid Ingredients market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Ribonucleic Acid Ingredients market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Ribonucleic Acid Ingredients market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Ribonucleic Acid Ingredients segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Ribonucleic Acid Ingredients segment by type and by application and regional segment by type and by application.
(6) Ribonucleic Acid Ingredients industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Messenger RNA
Transfer RNA
Ribosomal RNA
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Fluorescent Dyes
RT-PCR Enzymes
Transcription Reagents
Others
Understanding Market Segments by Key Players: Insights and Opportunities
BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics
1 Market Overview
1.1 Product Overview and Scope of Ribonucleic Acid Ingredients
1.2 Global Ribonucleic Acid Ingredients Market Size and Forecast
1.3 China Ribonucleic Acid Ingredients Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Ribonucleic Acid Ingredients Share in Global Market, 2018-2029
1.4.2 Ribonucleic Acid Ingredients Market Size: China VS Global, 2018-2029
1.5 Ribonucleic Acid Ingredients Market Dynamics
1.5.1 Ribonucleic Acid Ingredients Market Drivers
1.5.2 Ribonucleic Acid Ingredients Market Restraints
1.5.3 Ribonucleic Acid Ingredients Industry Trends
1.5.4 Ribonucleic Acid Ingredients Industry Policy
2 Global Competitive Situation by Company
2.1 Global Ribonucleic Acid Ingredients Revenue by Company (2018-2023)
2.2 Global Ribonucleic Acid Ingredients Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Ribonucleic Acid Ingredients Concentration Ratio
2.4 Global Ribonucleic Acid Ingredients Mergers & Acquisitions, Expansion Plans
2.5 Global Ribonucleic Acid Ingredients Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Ribonucleic Acid Ingredients Revenue by Company (2018-2023)
3.2 China Ribonucleic Acid Ingredients Ribonucleic Acid Ingredients Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Ribonucleic Acid Ingredients, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Ribonucleic Acid Ingredients Industry Chain
4.2 Ribonucleic Acid Ingredients Upstream Analysis
4.3 Ribonucleic Acid Ingredients Midstream Analysis
4.4 Ribonucleic Acid Ingredients Downstream Analysis
5 Sights by Type
5.1 Ribonucleic Acid Ingredients Classification
5.1.1 Messenger RNA
5.1.2 Transfer RNA
5.1.3 Ribosomal RNA
5.2 By Type, Global Ribonucleic Acid Ingredients Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Ribonucleic Acid Ingredients Revenue, 2018-2029
6 Sights by Application
6.1 Ribonucleic Acid Ingredients Segment by Application
6.1.1 Fluorescent Dyes
6.1.2 RT-PCR Enzymes
6.1.3 Transcription Reagents
6.1.4 Others
6.2 By Application, Global Ribonucleic Acid Ingredients Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Ribonucleic Acid Ingredients Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Ribonucleic Acid Ingredients Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Ribonucleic Acid Ingredients Market Size, 2018-2029
7.3 North America
7.3.1 North America Ribonucleic Acid Ingredients Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Ribonucleic Acid Ingredients Market Size Market Share
7.4 Europe
7.4.1 Europe Ribonucleic Acid Ingredients Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Ribonucleic Acid Ingredients Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Ribonucleic Acid Ingredients Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Ribonucleic Acid Ingredients Market Size Market Share
7.6 South America
7.6.1 South America Ribonucleic Acid Ingredients Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Ribonucleic Acid Ingredients Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Ribonucleic Acid Ingredients Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Ribonucleic Acid Ingredients Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Ribonucleic Acid Ingredients Market Size, 2018-2029
8.3.2 By Company, U.S. Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Ribonucleic Acid Ingredients Market Size, 2018-2029
8.4.2 By Company, Europe Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Ribonucleic Acid Ingredients Market Size, 2018-2029
8.5.2 By Company, China Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.5.3 By Type, China Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Ribonucleic Acid Ingredients Market Size, 2018-2029
8.6.2 By Company, Japan Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Ribonucleic Acid Ingredients Market Size, 2018-2029
8.7.2 By Company, South Korea Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Ribonucleic Acid Ingredients Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Ribonucleic Acid Ingredients Market Size, 2018-2029
8.9.2 By Company, India Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.9.3 By Type, India Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Ribonucleic Acid Ingredients Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Ribonucleic Acid Ingredients Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Ribonucleic Acid Ingredients Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 BioNTech SE
9.1.1 BioNTech SE Company Information, Head Office, Market Area and Industry Position
9.1.2 BioNTech SE Company Profile and Main Business
9.1.3 BioNTech SE Ribonucleic Acid Ingredients Models, Specifications and Application
9.1.4 BioNTech SE Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.1.5 BioNTech SE Recent Developments
9.2 Moderna
9.2.1 Moderna Company Information, Head Office, Market Area and Industry Position
9.2.2 Moderna Company Profile and Main Business
9.2.3 Moderna Ribonucleic Acid Ingredients Models, Specifications and Application
9.2.4 Moderna Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.2.5 Moderna Recent Developments
9.3 Abogen Biosciences
9.3.1 Abogen Biosciences Company Information, Head Office, Market Area and Industry Position
9.3.2 Abogen Biosciences Company Profile and Main Business
9.3.3 Abogen Biosciences Ribonucleic Acid Ingredients Models, Specifications and Application
9.3.4 Abogen Biosciences Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.3.5 Abogen Biosciences Recent Developments
9.4 Ionis Pharmaceuticals
9.4.1 Ionis Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.4.2 Ionis Pharmaceuticals Company Profile and Main Business
9.4.3 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Models, Specifications and Application
9.4.4 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.4.5 Ionis Pharmaceuticals Recent Developments
9.5 Sarepta Therapeutics
9.5.1 Sarepta Therapeutics Company Information, Head Office, Market Area and Industry Position
9.5.2 Sarepta Therapeutics Company Profile and Main Business
9.5.3 Sarepta Therapeutics Ribonucleic Acid Ingredients Models, Specifications and Application
9.5.4 Sarepta Therapeutics Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.5.5 Sarepta Therapeutics Recent Developments
9.6 Alnylam Pharmaceuticals
9.6.1 Alnylam Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.6.2 Alnylam Pharmaceuticals Company Profile and Main Business
9.6.3 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Models, Specifications and Application
9.6.4 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.6.5 Alnylam Pharmaceuticals Recent Developments
9.7 LARONDE, Inc.
9.7.1 LARONDE, Inc. Company Information, Head Office, Market Area and Industry Position
9.7.2 LARONDE, Inc. Company Profile and Main Business
9.7.3 LARONDE, Inc. Ribonucleic Acid Ingredients Models, Specifications and Application
9.7.4 LARONDE, Inc. Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.7.5 LARONDE, Inc. Recent Developments
9.8 Sirnaomics, Inc.
9.8.1 Sirnaomics, Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Sirnaomics, Inc. Company Profile and Main Business
9.8.3 Sirnaomics, Inc. Ribonucleic Acid Ingredients Models, Specifications and Application
9.8.4 Sirnaomics, Inc. Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.8.5 Sirnaomics, Inc. Recent Developments
9.9 Deep Genomics
9.9.1 Deep Genomics Company Information, Head Office, Market Area and Industry Position
9.9.2 Deep Genomics Company Profile and Main Business
9.9.3 Deep Genomics Ribonucleic Acid Ingredients Models, Specifications and Application
9.9.4 Deep Genomics Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.9.5 Deep Genomics Recent Developments
9.10 Nutcracker Therapeutics
9.10.1 Nutcracker Therapeutics Company Information, Head Office, Market Area and Industry Position
9.10.2 Nutcracker Therapeutics Company Profile and Main Business
9.10.3 Nutcracker Therapeutics Ribonucleic Acid Ingredients Models, Specifications and Application
9.10.4 Nutcracker Therapeutics Ribonucleic Acid Ingredients Revenue and Gross Margin, 2018-2023
9.10.5 Nutcracker Therapeutics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Ribonucleic Acid Ingredients Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|